[New large-scale studies with idraparinux, a prolonged action anticoagulant active via parenteral administration].
Samama
M-M
MM
D000925:Anticoagulants / Q000008:administration & dosage*; D003692:Delayed-Action Preparations / Q000008:administration & dosage; D006801:Humans; D007275:Injections, Intravenous; D009844:Oligosaccharides / Q000008:administration & dosage*; D010919:Placebos; D011655:Pulmonary Embolism / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D020246:Venous Thrombosis / Q000188:drug therapy / Q000517:prevention & control
D000925:Anticoagulants; D003692:Delayed-Action Preparations; D009844:Oligosaccharides; D010919:Placebos; C479958:idraparinux